Teligent, Inc. to Hold Conference Call for Fourth Quarter 2017 Results
Mar 12, 2018 20:30 pm UTC| Business
BUENA, N.J., March 12, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Thursday March 15, 2018 to...
21Vianet Group, Inc. Reports Unaudited Fourth Quarter and Full Year 2017 Financial Results
Mar 12, 2018 20:30 pm UTC| Business
Adjusted EBITDA up 228.9% YoY to RMB171.0 million Adjusted EBITDA margin expanded to 22.3% from 5.8% in prior year period BEIJING, March 12, 2018 -- 21Vianet Group, Inc. (Nasdaq:VNET) ("21Vianet" or the "Company"), a...
Vericel to Host Analyst and Investor Day on April 11, 2018
Mar 12, 2018 20:30 pm UTC| Business
CAMBRIDGE, Mass., March 12, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it will host an Analyst and Investor...
Mar 12, 2018 20:30 pm UTC| Business
WALTHAM, Mass., March 12, 2018 -- Radius Health, Inc. (Nasdaq:RDUS) a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in...
Mar 12, 2018 20:30 pm UTC| Business
TORONTO, March 12, 2018 -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announces that, further to its press release on March 9, 2018 whereby the Company...
Arch Therapeutics Provides Update on 510(k)
Mar 12, 2018 20:30 pm UTC| Business
FRAMINGHAM, Mass., March 12, 2018 -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it has utilized the Food...
Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors
Mar 12, 2018 20:30 pm UTC| Business
CAMBRIDGE, Mass., March 12, 2018 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the appointment of Michael Giordano, M.D., to the...